The FDA refused to accept uniQure's filing for AMT-130 last November, and earlier this year the Dutch biotech said it had ...

Details are starting to emerge of last week's cyberattack on Novo Nordisk, which now appears to have been a $25 million ...

As such, Google AI Overviews represent a major shift in search for the pharma industry, moving from traditional link-based ...

Capvaxive, which covers 21 strains of Streptococcus pneumoniae, has been approved since 2024 for the prevention of invasive ...

At ASCO 2026 in Chicago, Pedro Valencia, vice president of asset strategy leadership for oncology at AbbVie, joined ...

Biogen has dipped its toe into the M&A waters once again, agreeing to buy San Diego-based RayThera for up to $1 billion in ...

Men with a particular form of prostate cancer now have a targeted treatment for the first time, thanks to FDA approval of a ...

The late-stage MonumenTAL-3 trial of Talvey (talquetamab), given in combination with J&J and Genmab's anti-CD38 antibody ...

Poolbeg Pharma is preparing to start a clinical trial of a drug that aims to block a life-threatening side effect of cancer ...

A UK study has used dispensing data to understand how medicine use in England changed during and after the COVID-19 pandemic, ...

AbbVie's Aquipta can now be commissioned by the NHS in England and Wales as an acute treatment for migraine, adding to its ...

A new study will attempt to improve screening for one of the fastest-growing drug-resistant bacterial threats facing ...